Omid, the principal investigator overseeing an ARPA-H grant, is at the forefront of a compelling initiative aimed at advancing cancer therapy. In collaboration with co-founders Paul, Tzahi, and Susan, their joint endeavors are directed towards pioneering innovations with the potential to enhance outcomes for patients.
Learn more :
https://news.rice.edu/news/2023/feds-fund-45m-rice-led-research-could-slash-us-cancer-deaths-50